Bipolar Disorder
Study in Dallas and Austin, Texas

Request Information

To receive additional information and to be considered for a study at no cost to you, complete and submit the form below and someone from our patient experience team will contact you.

Join Our Studies

Bipolar Disorder

  • Extreme mood swings
  • Manic episodes
  • Depressive episodes
  • Impulsive or risky behavior
  • Difficulty concentrating or making decisions
  • Changes in sleep patterns, such as insomnia

At FutureSearch Trials, we conduct research studies on the treatment of bipolar disorder.

Eligible participants will be adults between the ages of 18 and 65 who are in generally good health. They must meet the DSM-5-TR criteria for bipolar I or II disorder without psychotic features and currently be experiencing a depressive episode lasting at least four weeks but not more than twelve months. Additionally, participants must have a minimum score of 20 on the HAMD-17 (Hamilton Depression Rating Scale) and a minimum score of 2 on Item 1 of the scale.

What is Bipolar Depression?

Bipolar disorder affects approximately 2.6% of the global population and is characterized by the cycling of depressive and manic episodes. Bipolar depression is marked by shifts in mood, energy, and activity levels. These episodes often last much longer than manic or hypomanic episodes, sometimes for weeks or months, and may involve sadness, fatigue, sleep changes, and loss of interest in everyday activities.

The mood changes experienced during the depressive episodes are a departure from your regular self and can deeply affect your everyday functioning. However, with the right approach and a better understanding of the disorder, symptoms can be managed.

Current Study Opportunities at FS Trials

Explore our latest clinical research studies designed to advance medical treatments and improve patient care. At FS Trials, we offer a range of study opportunities for various conditions, led by expert teams in state-of-the-art facilities. Learn how you can participate and contribute to meaningful medical progress.